A BILL 
To direct the Secretary of Health and Human Services, 
acting through the Director of the Centers for Disease 
Control and Prevention, to award grants to develop pro-
grams to increase health care providers’ awareness of 
Valley fever, and for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘End Valley Fever Now 
4
Act’’. 
5
01:44 Dec 27, 2019
H5438
2 
•HR 5438 IH
SEC. 2. GRANTS TO DEVELOP PROGRAMS TO INCREASE 
1
HEALTH CARE PROVIDERS’ AWARENESS OF 
2
VALLEY FEVER. 
3
Part P of title III of the Public Health Service Act 
4
(42 U.S.C. 280g et seq.) is amended by adding at the end 
5
the following: 
6
‘‘SEC. 399V–7. GRANTS TO DEVELOP PROGRAMS TO IN-
7
CREASE HEALTH CARE PROVIDERS’ AWARE-
8
NESS OF VALLEY FEVER. 
9
‘‘(a) IN GENERAL.—The Secretary, acting through 
10
the Administrator of the Health Resources and Services 
11
Administration and in consultation with the Director of 
12
the Centers for Disease Control and Prevention, shall 
13
make awards of grants or cooperative agreements to eligi-
14
ble entities to establish and carry out programs— 
15
‘‘(1) to increase health care providers’ aware-
16
ness of Valley fever; and 
17
‘‘(2) to educate and train health care providers 
18
on the diagnosis and treatment of Valley fever. 
19
‘‘(b) USE OF FUNDS.—An eligible entity selected to 
20
receive a grant or contract under this section shall use 
21
amounts awarded under such a grant or contract to pro-
22
vide innovative supportive activities (which may include 
23
activities that do not rely on the use of broadband serv-
24
ices) to enhance education through distance learning, con-
25
01:44 Dec 27, 2019
H5438
3 
•HR 5438 IH
tinuing educational activities, collaborative conferences, 
1
and electronic and telelearning activities. 
2
‘‘(c) AUTHORIZATION OF APPROPRIATIONS.—There 
3
are authorized to be appropriated to carry out this section 
4
$1,000,000 for the period of fiscal years 2021 through 
5
2023, to remain available until expended. 
6
‘‘(d) CONDITION.—A recipient of a grant under this 
7
section shall, as a condition on receipt of the grant, agree 
8
to develop curricula for the purposes specified in sub-
9
section (a) in coordination with local providers at hospitals 
10
and clinics. 
11
‘‘(e) DEFINITIONS.—In this section: 
12
‘‘(1) The term ‘eligible entity’ means— 
13
‘‘(A) a State department of health (or 
14
similar State authority); 
15
‘‘(B) an institution of higher education (as 
16
defined in section 101 of the Higher Education 
17
Act of 1965 (20 U.S.C. 1001)), including a 
18
medical school or continuing medical education 
19
program at such institution; 
20
‘‘(C) an entity operating a graduate med-
21
ical residency training program under section 
22
340E or under section 340H; or 
23
‘‘(D) a teaching hospital (as defined in sec-
24
tion 415.152 of title 42, Code of Federal Regu-
25
01:44 Dec 27, 2019
H5438
4 
•HR 5438 IH
lations) that has physicians and other medical 
1
providers with specialized knowledge in diag-
2
nosing and treating Valley fever. 
3
‘‘(2) The term ‘Valley fever’ means the condi-
4
tion caused by Coccidioidomycosis.’’. 
5
SEC. 3. STUDY COMPARING DIFFERENT CASE DEFINITIONS 
6
USED TO IDENTIFY VALLEY FEVER. 
7
(a) IN GENERAL.—The Secretary of Health and 
8
Human Services, acting through the Director of the Cen-
9
ters for Disease Control and Prevention shall conduct a 
10
study comparing different case definitions used to identify 
11
valley fever. Such study shall include the efficacy of the 
12
methods being used to establish such case definitions and 
13
the cost effectiveness of such methods, including using the 
14
case definition for valley fever established by the Council 
15
of State and Territorial Epidemiologist. 
16
(b) VALLEY FEVER DEFINED.—In this Act, the term 
17
‘‘Valley fever’’ has the meaning given the term in section 
18
399V–7 of the Public Health Service Act. 
19
01:44 Dec 27, 2019
H5438
5 
•HR 5438 IH
SEC. 4. ALLOWING STATES TO PROVIDE COVERAGE UNDER 
1
THE MEDICAID PROGRAM FOR ITEMS AND 
2
SERVICES FURNISHED IN CONNECTION WITH 
3
QUALIFYING 
VALLEY 
FEVER 
CLINICAL 
4
TRIALS. 
5
(a) IN GENERAL.—Section 1905(a) of the Social Se-
6
curity Act (42 U.S.C. 1396d(a)) is amended— 
7
(1) in paragraph (29), by striking ‘‘and’’ at the 
8
end; 
9
(2) by redesignating paragraph (30) as para-
10
graph (31); and 
11
(3) by inserting after paragraph (29) the fol-
12
lowing new paragraph: 
13
‘‘(30) items and services furnished in connec-
14
tion with participation in a qualifying Valley fever 
15
clinical trial (as defined in section 2709A(b)(4) of 
16
the Public Health Service Act), including travel and 
17
incidental expenses, regardless of whether such items 
18
and services are furnished by a participating pro-
19
vider under the Medicaid program (other than a pro-
20
vider excluded from participation in such program 
21
under section 1128) or whether such items and serv-
22
ices are furnished in another State; and’’. 
23
(b) REDUCTION IN FMAP FOR STATES THAT DO 
24
NOT PROVIDE COVERAGE.—Section 1905 of the Social 
25
Security Act (42 U.S.C. 1396d) is amended— 
26
01:44 Dec 27, 2019
H5438
6 
•HR 5438 IH
(1) in subsection (b), by striking ‘‘and (ff)’’ and 
1
inserting ‘‘(ff), and (gg)’’; and 
2
(2) by adding at the end the following new sub-
3
section: 
4
‘‘(gg) REDUCTION IN FMAP FOR STATES THAT DO 
5
NOT PROVIDE COVERAGE
FOR CERTAIN ITEMS
AND 
6
SERVICES.—With respect to a calendar quarter beginning 
7
on or after January 1, 2021, the Federal medical assist-
8
ance percentage otherwise determined under subsection 
9
(b) for a State that does not provide coverage for items 
10
and services described in subsection (a)(30) that are fur-
11
nished during such quarter shall be reduced by 5 percent-
12
age points.’’. 
13
(c) ENSURING ACCESS FOR MEDICAID EXPANSION 
14
15
ed by inserting before the period at the end the following: 
16
‘‘, and beginning January 1, 2021, coverage of items and 
17
services described in section 1905(a)(30)’’. 
18
(d) PROHIBITION ON IMPOSITION OF COSTSHARING 
19
REQUIREMENTS.—Title XIX of the Social Security Act 
20
(42 U.S.C. 1396 et seq.) is amended— 
21
(1) in section 1916(a)(2)— 
22
(A) in subparagraph (D), by striking ‘‘or’’ 
23
at the end; 
24
01:44 Dec 27, 2019
H5438
7 
•HR 5438 IH
(B) in subparagraph (E), by striking ‘‘; 
1
and’’ at the end and inserting ‘‘, or’’; and 
2
(C) by adding at the end the following new 
3
subparagraph: 
4
‘‘(F) items and services described in sec-
5
tion 1905(a)(30); and’’; and 
6
(2) in section 1916A(b)(3)(B), by adding at the 
7
end the following new clause: 
8
‘‘(xi) Items and services described in 
9
section 1905(a)(30).’’. 
10
(e) CONTINUOUS COVERAGE FOR INDIVIDUALS WHO 
11
LOSE MEDICAID ELIGIBILITY BASED ON INCOME.—Sec-
12
tion 1902(e) of the Social Security Act (42 U.S.C. 
13
1396a(e)) is amended by adding at the end the following 
14
new paragraph: 
15
‘‘(16) CONTINUOUS COVERAGE FOR ITEMS AND 
16
SERVICES FURNISHED IN CONNECTION WITH QUALI-
17
FYING
VALLEY
FEVER
CLINICAL
TRIALS.—In the 
18
case of an individual who is eligible for medical as-
19
sistance under the State plan (or a waiver of such 
20
plan) based on the application of modified adjusted 
21
gross income under paragraph (14)(A), who while so 
22
eligible is furnished items and services described in 
23
section 1905(a)(30) in connection with participation 
24
in a qualifying Valley fever clinical trial (as defined 
25
01:44 Dec 27, 2019
H5438
8 
•HR 5438 IH
in section 2709A(b)(4) of the Public Health Service 
1
Act), and who while so furnished such items and 
2
services loses eligibility for such medical assistance 
3
due to a change in income of the family of which 
4
such individual is a member, such individual shall be 
5
deemed to continue to be an individual eligible for 
6
such medical assistance, without regard to such 
7
change in income, only with respect to such items 
8
and services through the end of the month in which 
9
such qualifying Valley fever clinical trial ends.’’. 
10
(f) EFFECTIVE DATE.— 
11
(1) IN GENERAL.—The amendments made by 
12
this section shall apply with respect to items and 
13
services furnished, and eligibility determinations 
14
made, on or after January 1, 2021. 
15
(2) EXCEPTION FOR STATE LEGISLATION.—In 
16
the case of a State plan under title XIX of the So-
17
cial Security Act (42 U.S.C. 1396 et seq.) that the 
18
Secretary of Health and Human Services determines 
19
requires State legislation in order for the respective 
20
plan to meet any requirement imposed by amend-
21
ments made by this section, the respective plan shall 
22
not be regarded as failing to comply with the re-
23
quirements of such title solely on the basis of its 
24
failure to meet such an additional requirement be-
25
01:44 Dec 27, 2019
H5438
9 
•HR 5438 IH
fore the first day of the first calendar quarter begin-
1
ning after the close of the first regular session of the 
2
State legislature that begins after the date of the en-
3
actment of this Act. For purposes of the previous 
4
sentence, in the case of a State that has a 2-year 
5
legislative session, each year of the session shall be 
6
considered to be a separate regular session of the 
7
State legislature. 
8
SEC. 5. REQUIREMENT FOR GROUP HEALTH PLANS AND 
9
HEALTH INSURANCE ISSUERS TO PROVIDE 
10
COVERAGE FOR ITEMS AND SERVICES FUR-
11
NISHED IN CONNECTION WITH QUALIFYING 
12
VALLEY FEVER CLINICAL TRIALS. 
13
(a) IN GENERAL.—Subpart I of part A of title 
14
XXVII of the Public Health Service Act (42 U.S.C. 300gg 
15
et seq.) is amended— 
16
(1) by redesignating the second section 2709 as 
17
section 2710; and 
18
(2) by inserting after the first section 2709 the 
19
following new section: 
20
‘‘SEC. 2709A. COVERAGE FOR INDIVIDUALS PARTICIPATING 
21
IN QUALIFYING VALLEY FEVER CLINICAL 
22
TRIALS. 
23
‘‘(a) IN GENERAL.—Notwithstanding section 2709, a 
24
group health plan or health insurance issuer offering 
25
01:44 Dec 27, 2019
H5438
10 
•HR 5438 IH
group or individual health insurance coverage shall, with 
1
respect to an enrollee of such plan or coverage, respec-
2
tively, provide coverage for any item or service furnished 
3
to such enrollee in connection with such enrollee’s partici-
4
pation in a qualifying Valley fever clinical trial, including 
5
travel and incidental expenses— 
6
‘‘(1) without regard to whether such item or 
7
service is furnished by a participating provider or 
8
participating facility with respect to such item or 
9
service; and 
10
‘‘(2) in a manner so that, if such item or serv-
11
ice is furnished to such enrollee by a nonpartici-
12
pating provider or nonparticipating facility, the cost- 
13
sharing requirement (expressed as a copayment 
14
amount or coinsurance rate) is not greater than the 
15
requirement that would apply if such item or service 
16
were furnished by a participating provider or partici-
17
pating facility. 
18
‘‘(b) DEFINITIONS.—In this section: 
19
‘‘(1) NONPARTICIPATING
FACILITY; PARTICI-
20
PATING FACILITY.— 
21
‘‘(A) NONPARTICIPATING
FACILITY.—The 
22
term ‘nonparticipating facility’ means, with re-
23
spect to an item or service and a group health 
24
plan or group or individual health insurance 
25
01:44 Dec 27, 2019
H5438
11 
•HR 5438 IH
coverage, a health care facility that does not 
1
have a contractual relationship with the sponsor 
2
of such plan or issuer of such coverage for fur-
3
nishing such item or service under the plan or 
4
coverage. 
5
‘‘(B) PARTICIPATING FACILITY.—The term 
6
‘participating facility’ means, with respect to an 
7
item or service and a group health plan or 
8
group or individual health insurance coverage, a 
9
health care facility that has a contractual rela-
10
tionship with the sponsor of such plan or issuer 
11
of such coverage for furnishing such item or 
12
service under the plan or coverage. 
13
‘‘(2) NONPARTICIPATING
PROVIDER; PARTICI-
14
PATING PROVIDER.— 
15
‘‘(A) NONPARTICIPATING PROVIDER.—The 
16
term ‘nonparticipating provider’ means, with re-
17
spect to an item or service and a group health 
18
plan or group or individual health insurance 
19
coverage, a physician or other health care pro-
20
vider who is acting within the scope of practice 
21
of that provider’s license or certification under 
22
applicable State law and who does not have a 
23
contractual relationship with the sponsor of 
24
such plan or issuer of such coverage for fur-
25
01:44 Dec 27, 2019
H5438
12 
•HR 5438 IH
nishing such item or service under the plan or 
1
coverage. 
2
‘‘(B) 
PARTICIPATING
PROVIDER.—The 
3
term ‘participating provider’ means, with re-
4
spect to an item or service and a group health 
5
plan or group or individual health insurance 
6
coverage, a physician or other health care pro-
7
vider who is acting within the scope of practice 
8
of that provider’s license or certification under 
9
applicable State law and who has a contractual 
10
relationship with the sponsor of such plan or 
11
issuer of such coverage for furnishing such item 
12
or service under the plan or coverage. 
13
‘‘(3) QUALIFYING
VALLEY
FEVER
CLINICAL 
14
TRIAL.— 
15
‘‘(A) IN GENERAL.—The term ‘qualifying 
16
Valley fever clinical trial’ means a phase I, 
17
phase II, phase III, or phase IV clinical trial 
18
that is conducted in relation to the prevention, 
19
detection, or treatment of Valley fever (as de-
20
fined in section 399V–7) and is described in 
21
any of the following clauses: 
22
‘‘(i) The study or investigation is ap-
23
proved or funded (which may include fund-
24
01:44 Dec 27, 2019
H5438
13 
•HR 5438 IH
ing through in-kind contributions) by one 
1
or more of the following: 
2
‘‘(I) The National Institutes of 
3
Health. 
4
‘‘(II) The Centers for Disease 
5
Control and Prevention. 
6
‘‘(III) The Agency for Healthcare 
7
Research and Quality. 
8
‘‘(IV) The Centers for Medicare 
9
& Medicaid Services. 
10
‘‘(V) A cooperative group or cen-
11
ter of any of the entities described in 
12
subclauses (I) through (IV) or the De-
13
partment of Defense or the Depart-
14
ment of Veterans Affairs. 
15
‘‘(VI) A qualified non-govern-
16
mental research entity identified in 
17
the guidelines issued by the National 
18
Institutes of Health for center support 
19
grants. 
20
‘‘(VII) Any of the following if the 
21
conditions described in subparagraph 
22
(B) are met: 
23
‘‘(aa) The Department of 
24
Veterans Affairs. 
25
01:44 Dec 27, 2019
H5438
14 
•HR 5438 IH
‘‘(bb) The Department of 
1
Defense. 
2
‘‘(cc) The Department of 
3
Energy. 
4
‘‘(ii) The clinical trial is conducted 
5
under an investigational new drug applica-
6
tion reviewed by the Food and Drug Ad-
7
ministration. 
8
‘‘(iii) The clinical trial is a drug trial 
9
that is exempt from having such an inves-
10
tigational new drug application. 
11
‘‘(B) CONDITIONS.—For purposes of sub-
12
paragraph (A)(i)(VII), the conditions described 
13
in this subparagraph, with respect to a clinical 
14
trial approved or funded by an entity described 
15
in such subparagraph (A)(i)(VII), are that the 
16
clinical trial has been reviewed and approved 
17
through a system of peer review that the Sec-
18
retary determines— 
19
‘‘(i) to be comparable to the system of 
20
peer review of studies and investigations 
21
used by the National Institutes of Health; 
22
and 
23
‘‘(ii) assures unbiased review of the 
24
highest scientific standards by qualified in-
25
01:44 Dec 27, 2019
H5438
15 
•HR 5438 IH
dividuals with no interest in the outcome 
1
of the review.’’. 
2
(b) EFFECTIVE DATE.—The amendments made by 
3
this section shall apply with respect to plan years begin-
4
ning on or after January 1, 2021. 
5
SEC. 6. MEDICARE COVERAGE OF ITEMS AND SERVICES 
6
FURNISHED IN CONNECTION WITH QUALI-
7
FYING VALLEY FEVER CLINICAL TRIALS. 
8
(a) COVERAGE.—Section 1861(s)(2) of the Social Se-
9
curity Act (42 U.S.C. 1395x(s)(2)) is amended— 
10
(1) in subparagraph (GG), by striking ‘‘and’’ at 
11
the end; 
12
(2) in subparagraph (HH), by striking the pe-
13
riod at the end and inserting ‘‘; and’’; and 
14
(3) by adding at the end the following new sub-
15
paragraph: 
16
‘‘(II) items and services furnished in connection 
17
with participation in a qualifying Valley fever clinical 
18
trial (as defined in section 2709A(b)(4) of the Public 
19
Health Service Act), including travel and incidental 
20
expenses;’’. 
21
(b) PAYMENT.—Section 1833(a)(1) of the Social Se-
22
curity Act (42 U.S.C. 1395l(a)(1)) is amended— 
23
(1) by striking ‘‘and (CC)’’ and inserting 
24
‘‘(CC)’’; and 
25
01:44 Dec 27, 2019
H5438
16 
•HR 5438 IH
(2) by inserting before the semicolon at the end 
1
the following: ‘‘, and (DD) with respect to items and 
2
services described in section 1861(s)(2)(II), the 
3
amount paid shall be 100 percent of the lesser of the 
4
actual charge for the services or the amount deter-
5
mined under the payment basis determined under 
6
section 1848’’. 
7
Æ 
01:44 Dec 27, 2019
H5438
